Sign in

CIK 0001822791

  • Non-accelerated filer
  • Smaller reporting company
Ticker
CLNN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
852828339
Phone
+1 801-676-9695
Business address
6550 SOUTH MILLROCK DRIVE, SUITE G50, SALT LAKE CITY, UT, 84121
Former names
Chelsea Worldwide Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-04-30 Jeong Tae Heum Chief Finance Officer Grant or award · Stock Options (Right to buy) +20,000 20,000
2021-04-30 Glanzman Robert Chief Medical Officer Grant or award · Stock Options (Right to buy) +95,000 95,000
2021-04-30 WILCOX REED N Director Grant or award · Stock Options (Right to buy) +45,000 45,000
2021-04-30 Ugwumba Chidozie Director Grant or award · Stock Options (Right to buy) +45,000 45,000
2021-04-30 MATLIN DAVID J Director Grant or award · Stock Options (Right to buy) +45,000 45,000
2021-04-30 Stevens John Henry Director Grant or award · Stock Options (Right to buy) +45,000 45,000
2021-04-30 Mosca Alison Director Grant or award · Stock Options (Right to buy) +45,000 45,000
2021-04-30 Jacobovitz Shalom Director Grant or award · Stock Options (Right to buy) +45,000 45,000
2021-04-30 Gay Jonathon Director Grant or award · Stock Options (Right to buy) +45,000 45,000
2021-02-01 Jeong Tae Heum Chief Finance Officer Grant or award · Stock Options (Right to buy) +130,000 $6.55 $852K 130,000

Page 24 of 24 · 470 trades